Sanofi - Aventis Groupe: Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based immunotherapy
Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based immunotherapy Origimm brings expertise in antigen discovery for immune modulation of skin microbiome-associated